Adonis raised a $40 million Series C funding round to help hospitals use AI to tackle denied and underpaid claims. Its platform automates manual revenue cycle tasks and provides real-time insights, which allows staff to focus on higher-value work. Customers include Mount Sinai Health System, Baptist Health South Florida, AdventHealth and ApolloMD.
Turquoise Health raised $40 million in a Series C round to expand beyond price transparency into managing healthcare contracts. The startup’s platform aims to simplify payer–provider agreements, reduce administrative waste and enable patients to see guaranteed upfront prices.
How to turn analytics into actual policy outcomes.
Health advocate network Solace Health gained unicorn status after closing a $130 million Series C funding round. The startup’s advocates help with tasks like scheduling appointments, finding in-network providers, understanding insurance coverage and bills, and coordinating care across multiple clinicians. And they actually handle much of the work on a patient’s behalf, rather than simply telling patients what steps to take next.
Digital health engagement app Wellth raised $36 million in Series C funding to expand its “daily care motivation platform,” which uses small financial incentives and dopamine-driven nudges to keep patients engaged in healthy behaviors.
Ambience Healthcare closed a $243 million Series C funding round, bringing its valuation to $1.25 billion. The startup, which offers an AI-powered platform for clinical documentation and coding, aims to reduce clinician burnout by automating time-consuming administrative tasks across a wide range of specialties.
Cohere Health raked in $90 million in Series C capital, taking its total funding to date to $200 million. This round of funding cements Cohere as the emerging winner in the prior authorization tech category, according to Michael Greeley, general partner at Flare Capital Partners.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models.
Sibel Health raised $30 million to accelerate the commercial deployment of its remote patient monitoring platform. The company also announced its seventh FDA clearance, which enables clinicians to use alarms and alerts along with the Sibel’s central platform.
Caresyntax closed a $180 million Series C extension round, bringing its Series C fundraising total to $310 million. The company sells AI-based precision surgery technology that unifies operating room data on a single platform.
Two Chairs, a startup offering hybrid behavioral health care, closed a $72 million Series C funding round. The company’s focus on measuring outcomes and dedication to care quality assurance are two key factors that differentiate it from other mental health startups, CEO Alex Katz said.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Cytovale, a San Francisco-based medical diagnostics company, raised $84 million in Series C funds to advance the commercialization of its diagnostic test for early sepsis detection. Using standard blood draws, the test provides results in under 10 minutes. It is meant to detect sepsis in patients who present to hospital emergency departments.
Providence spinout DexCare recently closed a $75 million Series C funding round, bringing its total funding to date to $146 million. The startup gives health systems a platform that helps them coordinate and manage digital care services so they can better address the modern healthcare consumer's demands for convenience and immediacy.
Medallion — a provider management platform that automates licensing, continuing education tracking, credentialing and compliance — has completed three funding rounds in one year. On Thursday, it closed a $35 million Series C round, which will be used to help the startup attract more hospital and health system customers.
NexHealth raised $125 million in a Series C funding round that was led by Buckley Ventures, the patient experience platform announced Thursday. The latest investment brings the company's valuation to $1 billion.
Vera Therapeutics licensed the drug candidate after analysis of earlier trials revealed its promise. Boosted by $80 million in Series C funding, the company hopes to launch a phase 2B trial this year.